Add time:09/02/2019         Source:sciencedirect.com

An efficient and convergent method for the synthesis of mannose-1-phosphate prodrugs is described as a potential therapy for congenital disorders of glycosylation-Ia (CDG-Ia). The key feature of the proposed approach is the silver assisted nucleophilic substitution of 2,3,4,6-tetra-O-protected-α-d-mannopyranosyl bromides with various silver phosphate salts to afford mono, di, and tri-mannopyranosyl phosphates. A preliminary biological evaluation of the synthesized phosphate prodrugs has been carried out.

We also recommend Trading Suppliers and Manufacturers of guanosine 3'-(dihydrogen phosphate) (cas 117-68-0). Pls Click Website Link as below: cas 117-68-0 suppliers